Fundraising Fox
David Schnell
InvestorManaging Director at Prospect Venture Partners · Board director at Ngm Biopharmaceuticals
Menlo Park, California
Find your path to David
17 people in our graph can introduce you to David.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Russell Hirsch to introduce you to David
You →Russell · together at Prospect Venture Partners →David
Ask Jamie Chen to introduce you to David
You →Jamie · 10 people · together at Prospect Venture Partners →David
Ask Sam Okafor to introduce you to David
You →Sam · together at Ngm Biopharmaceuticals →David
Sign up to find every way you can get introduced to David
- Your email: the people you already email who know David
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with David
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
David Schnell is a Managing Director who co-founded Prospect Ventures in 1997, a firm focused on biomedical companies. He was previously a Partner at Kleiner Perkins Caufield & Byers, where he invested in early-stage biotechnology companies, and co-founded and served as CEO of Healtheon Corporation, which later merged with WebMD. Earlier he spent seven years at Sandoz Pharmaceuticals (now Novartis) in executive roles; he holds an MD from Harvard Medical School and an MA and BS from Stanford.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Ngm Biopharmaceuticals
Intro paths
In turn, David can intro founders to Ngm Biopharmaceuticals's investors below.
Ngm Biopharmaceuticals's investors · 3
Co-founders at Ngm Biopharmaceuticals
Investments
Board seats
AmiraGloucester PharmaceuticalsKythera BiopharmaceuticalsNgm BiopharmaceuticalsRinat NeurosciencesSenomyxTrubion
Per the firm's website.
Colleagues at Prospect Venture Partners
Frequently asked questions
- Who is David Schnell?
- David Schnell is a Managing Director who co-founded Prospect Ventures in 1997, a firm focused on biomedical companies. He was previously a Partner at Kleiner Perkins Caufield & Byers, where he invested in early-stage biotechnology companies, and co-founded and served as CEO of Healtheon Corporation, which later merged with WebMD. Earlier he spent seven years at Sandoz Pharmaceuticals (now Novartis) in executive roles; he holds an MD from Harvard Medical School and an MA and BS from Stanford.
- Where does David Schnell work?
- David Schnell is Managing Director at Prospect Venture Partners and Board director at Ngm Biopharmaceuticals.
- What does David Schnell invest in?
- David Schnell invests in Biotech.
- What boards does David Schnell sit on?
- David Schnell holds tracked board seats at Amira, Gloucester Pharmaceuticals, Kythera Biopharmaceuticals, Ngm Biopharmaceuticals, Rinat Neurosciences, Senomyx, Trubion.